Koers Johnson & Johnson Buenos Aires S.E.
Aandelen
DJNJ3D
ARDEUT112687
Farmaceutische producten
Omzet 2024 * | 88,35 mld. 78.984 mld. 81,33 mld. | Omzet 2025 * | 90,76 mld. 81.141 mld. 83,55 mld. | Marktkapitalisatie | 354 mld. 316.216 mld. 326 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 22,04 mld. 19.703 mld. 20,29 mld. | Nettowinst (verlies) 2025 * | 23,09 mld. 20.644 mld. 21,26 mld. | EV/omzet 2024 * | 3,92 x |
Nettoliquiditeiten 2024 * | 7 mld. 6.255 mld. 6,44 mld. | Nettoliquiditeiten 2025 * | 19,84 mld. 17.739 mld. 18,27 mld. | EV/omzet 2025 * | 3,68 x |
K/w-verhouding 2024 * |
16,3
x | K/w-verhouding 2025 * |
15,4
x | Werknemers | 131.900 |
Dividendrendement 2024 * |
3,28% | Dividendrendement 2025 * |
3,43% | Vrij verhandelbaar | 77,08% |
Recentste transcriptie over Johnson & Johnson
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01-01-89 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01-01-98 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25-04-19 |
D. Davis
BRD | Director/Board Member | 72 | 19-06-14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22-10-09 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-05-24 | 1.250 | -.--% | 9 |
23-05-24 | 1.250 | -.--% | 11 |
slotkoers Buenos Aires S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+37,25% | 727 mld. | |
+15,46% | 328 mld. | |
-0,59% | 277 mld. | |
+13,47% | 243 mld. | |
+7,35% | 205 mld. | |
-6,42% | 203 mld. | |
+3,85% | 164 mld. | |
-2,01% | 164 mld. | |
-1,31% | 122 mld. |